FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Emmanuel Fenouillet

Research Profile

Chemicals & Drugs

Living Beings

Phenomena

Glycosylation

Anatomy

Co-author Network

Publications

TOP 3
Pierre-Julien Moro; Jacques Quilici; Jean Ruf; Yves Jammes; Jean-Louis Bonnet; ALAIN BOUSSUGES; Youlet By; Thomas Cuisset; Emmanuel Fenouillet; Roch Giorgi; Régis Guieu
Mononuclear cell adenosine deaminase and CD26/dipeptidylpeptidase-IV activities are sensitive markers of reperfusion during percutaneous transluminal angioplasty.
Imed Regaya; Jean-Marc Sabatier; Sabrine Aidi-Knani; Jeannette Ben Hamida; Jean-Louis Berge-Lefranc; Youlet By; Jocelyne Condo; Emmanuel Fenouillet; Victoria Gerolami; Régis Guieu; Jean Ruf
SKCa Channels Blockage Increases the Expression of Adenosine A2A Receptor in Jurkat Human T Cells.
Régis Guieu; Jean Marc Leveque; Jean Claude Peragut; Jean Régis; Youlet By; Alix Dousset; Emmanuel Fenouillet; Roch Giorgi; Eric Guedj; Jean Ruf; Veronique Tuzzolino; Philippe Roussel
High cell surface CD26-associated activities and low plasma adenosine concentration in fibromyalgia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Emmanuel Fenouillet (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pierre-Julien Moro; Jacques Quilici; Jean Ruf; Yves Jammes; Jean-Louis Bonnet; ALAIN BOUSSUGES; Youlet By; Thomas Cuisset; Emmanuel Fenouillet; Roch Giorgi; Régis Guieu
Mononuclear cell adenosine deaminase and CD26/dipeptidylpeptidase-IV activities are sensitive markers of reperfusion during percutaneous transluminal angioplasty.
International journal of cardiology 2013;166(1):225-9.
2013: Imed Regaya; Jean-Marc Sabatier; Sabrine Aidi-Knani; Jeannette Ben Hamida; Jean-Louis Berge-Lefranc; Youlet By; Jocelyne Condo; Emmanuel Fenouillet; Victoria Gerolami; Régis Guieu; Jean Ruf
SKCa Channels Blockage Increases the Expression of Adenosine A2A Receptor in Jurkat Human T Cells.
BioResearch open access 2013;2(2):163-8.
2012: Régis Guieu; Jean Marc Leveque; Jean Claude Peragut; Jean Régis; Youlet By; Alix Dousset; Emmanuel Fenouillet; Roch Giorgi; Eric Guedj; Jean Ruf; Veronique Tuzzolino; Philippe Roussel
High cell surface CD26-associated activities and low plasma adenosine concentration in fibromyalgia.
Annals of the rheumatic diseases 2012;71(8):1427-8.
2010: Youlet By; Josée-Martine Durand-Gorde; Jocelyne Condo; Pierre-Jean Lejeune; Emmanuel Fenouillet; Régis Guieu; Jean Ruf
Monoclonal antibody-assisted stimulation of adenosine A2A receptors induces simultaneous downregulation of CXCR4 and CCR5 on CD4+ T-cells.
Human immunology 2010;71(11):1073-6.
2010: Marie-Jeanne Papandréou; Rym Barbouche; Régis Guieu; Santiago Rivera; Jacques Fantini; Michel Khrestchatisky; Ian M Jones; Emmanuel Fenouillet
Mapping of domains on HIV envelope protein mediating association with calnexin and protein-disulfide isomerase.
The Journal of biological chemistry 2010;285(18):13788-96.
2010: Oualid Sbai; Adlane Ould-Yahoui; Lotfi Ferhat; Yatma Gueye; Anne Bernard; Eliane Charrat; Ali Mehanna; Jean-Jacques Risso; Jean-Paul Chauvin; Emmanuel Fenouillet; Santiago Rivera; Michel Khrestchatisky
Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes.
Glia 2010;58(3):344-66.
2008: Emmanuel Fenouillet; Dimitri Lavillette; Silvia Loureiro; George Krashias; Guillemette Maurin; François-Loïc Cosset; Ian M Jones; Rym Barbouche
Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity.
The Journal of biological chemistry 2008;283(39):26340-8.
2007: Emmanuel Fenouillet; Rym Barbouche; Ian M Jones
Cell entry by enveloped viruses: redox considerations for HIV and SARS-coronavirus.
Antioxidants & redox signaling 2007;9(8):1009-34.
2007: Louis Carrega; Alain Saadjian; Laurence Mercier; Ibrahim Zouher; Jean-Louis Bergé-Lefranc; Victoria Gerolami; Philippe Giaime; Pascal Sbragia; Franck Paganelli; Emmanuel Fenouillet; Samuel Lévy; Régis Guieu
Increased expression of adenosine A2A receptors in patients with spontaneous and head-up-tilt-induced syncope.
Heart rhythm : the official journal of the Heart Rhythm Society 2007;4(7):870-6.
2007: Louis Carrega; Emmanuel Fenouillet; Philippe Giaime; Annie Charavil; Laurence Mercier; Victoria Gerolami; Jean-Louis Berge-Lefranc; Yvon Berland; Jean Ruf; Alain Saadjian; Bertrand Dussol; Régis Guieu
Influence of haemodialysis and left ventricular failure on peripheral A(2A) adenosine receptor expression.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(3):851-6.
2006: Philippe Giaime; Louis Carrega; Emmanuel Fenouillet; Laurence Mercier; Victoria Gerolami; Jean Ruf; Nicole Sauze; Philippe Brunet; Alain Saadjian; Yvon Berland; Bertrand Dussol; Régis Guieu
Relationship between A2A adenosine receptor expression and intradialytic hypotension during hemodialysis.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2006;54(8):473-7.
2006: Malika El Yacoubi; Jean-Marie Vaugeois; Didier Marguet; Nicole Sauze; Régis Guieu; Jean Costentin; Emmanuel Fenouillet
Behavioral characterization of CD26 deficient mice in animal tests of anxiety and antidepressant-like activity.
Behavioural brain research 2006;171(2):279-85.
2006: Dimitri Lavillette; Rym Barbouche; Yongxiu Yao; Bertrand Boson; François-Loïc Cosset; Ian M Jones; Emmanuel Fenouillet
Significant redox insensitivity of the functions of the SARS-CoV spike glycoprotein: comparison with HIV envelope.
The Journal of biological chemistry 2006;281(14):9200-4.
2006: Régis Guieu; Emmanuel Fenouillet; Christiane Devaux; Ziad Fajloun; Louis Carrega; Jean-Marc Sabatier; Nicole Sauze; Didier Marguet
CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity.
Behavioural brain research 2006;166(2):230-5.
2005: Rym Barbouche; Hugues Lortat-Jacob; Ian M Jones; Emmanuel Fenouillet
Glycosaminoglycans and protein disulfide isomerase-mediated reduction of HIV Env.
Molecular pharmacology 2005;67(4):1111-8.
2004: Bertrand Dussol; Emmanuel Fenouillet; Philippe Brunet; Raj Purgus; Nicole Sauze; Louis Carrega; Laurence Mercier; Ibrahim Zouher; Guy Bechis; Yvon Berland; Régis Guieu
Kinetic study of adenosine concentrations and the expression of adenosine deaminase in mononuclear cells during hemodialysis.
Kidney international 2004;66(4):1640-6.
2004: Emmanuel Fenouillet; Rym Barbouche; Ian M Jones
HIV Env reduction postreceptor binding: a new target for AIDS treatment?
Blood 2004;104(1):296.
2003: Rym Barbouche; Raymond Miquelis; Ian M Jones; Emmanuel Fenouillet
Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion.
The Journal of biological chemistry 2003;278(5):3131-6.
2002: Rym Barbouche; E Feyfant; B Belhaj; Emmanuel Fenouillet
Pharmacophore determination of a gp120 C terminal-derived anti-HIV peptide construct interfering with membrane fusion suggesting that processing of the gp120 C terminus is a prelude to fusion.
AIDS research and human retroviruses 2002;18(3):201-6.
2002: Marie-Jeanne Papandréou; Rym Barbouche; Régis Guieu; Marie Paule Kieny; Emmanuel Fenouillet
The alpha-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step.
Molecular pharmacology 2002;61(1):186-93.
2001: JJ Sampol; Bertrand Dussol; Emmanuel Fenouillet; Christian Capo; J L Mege; Gilles Halimi; Guy Bechis; Philippe Brunet; Hervé Rochat; Yvon Berland; Régis Guieu
High adenosine and deoxyadenosine concentrations in mononuclear cells of hemodialyzed patients.
Journal of the American Society of Nephrology : JASN 2001;12(8):1721-8.
2001: Emmanuel Fenouillet; Rym Barbouche; J Courageot; Raymond Miquelis
The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope-mediated membrane fusion after CD4 cell binding.
The Journal of infectious diseases 2001;183(5):744-52.
2001: Régis Guieu; Philippe Brunet; JJ Sampol; Guy Bechis; Emmanuel Fenouillet; J L Mege; Christian Capo; J Vitte; Z Ibrahim; Louis Carrega; D Lerda; Hervé Rochat; Yvon Berland; Bertrand Dussol
Adenosine and hemodialysis in humans.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2001;49(1):56-67.
2000: Rym Barbouche; Etienne Decroly; Marie Paule Kieny; Emmanuel Fenouillet
An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Virology 2000;273(1):169-77.
2000: Rym Barbouche; Marie-Jeanne Papandréou; Raymond Miquelis; Régis Guieu; Emmanuel Fenouillet
Relationships between the anti-HIV V(3)-derived peptide SPC(3) and lymphocyte membrane properties involved in virus entry: SPC(3) interferes with CXCR(4).
FEMS microbiology letters 2000;183(2):235-40.
1999: J Courageot; Emmanuel Fenouillet; P Bastiani; Raymond Miquelis
Intracellular degradation of the HIV-1 envelope glycoprotein. Evidence for, and some characteristics of, an endoplasmic reticulum degradation pathway.
European journal of biochemistry / FEBS 1999;260(2):482-9.
1998: Rym Barbouche; Raymond Miquelis; Jean-Marc Sabatier; Emmanuel Fenouillet
SPC3, an anti-HIV peptide construct derived from the viral envelope, binds and enters HIV target cells.
Journal of peptide science : an official publication of the European Peptide Society 1998;4(8):479-85.
1998: Rym Barbouche; Naziha Marrakchi; Kamel Mabrouk; Mohamed Naceur Krifi; Jurphaas van Rietschoten; Emmanuel Fenouillet; Mohamed El Ayeb; Hervé Rochat
Anti-platelet activity of the peptides composing the lebetin 1 family, a new class of inhibitors of platelet aggregation.
Toxicon : official journal of the International Society on Toxinology 1998;36(12):1939-47.
1998: Rym Barbouche; Emmanuel Fenouillet; Marie-Jeanne Papandréou; M P Kiény; Jean-Marc Sabatier
Properties of HIV envelope expressed in the presence of SPC3, an Env-derived peptide drug under phase II clinical trials.
The journal of peptide research : official journal of the American Peptide Society 1998;52(4):283-8.
1998: Rym Barbouche; Jean-Marc Sabatier; Emmanuel Fenouillet
An anti-HIV peptide construct derived from the cleavage region of the Env precursor acts on Env fusogenicity through the presence of a functional cleavage sequence.
Virology 1998;247(2):137-43.
1998: C Perrin; Emmanuel Fenouillet; Ian M Jones
Role of gp41 glycosylation sites in the biological activity of human immunodeficiency virus type 1 envelope glycoprotein.
Virology 1998;242(2):338-45.
1998: M J Papandreou; Emmanuel Fenouillet
Effect of changes in the glycosylation of the human immunodeficiency virus type 1 envelope on the immunoreactivity and sensitivity to thrombin of its third variable domain.
Virology 1998;241(1):163-7.
1997: Emmanuel Fenouillet; Marie-Jeanne Papandréou; Ian M Jones
Recombinant HIV envelope expressed in an alpha-glucosidase I-deficient CHO cell line and its parental cell line in the presence of 1-deoxynojirimycin is functional.
Virology 1997;231(1):89-95.
1997: M J Papandreou; Emmanuel Fenouillet
Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation.
FEBS letters 1997;406(1-2):191-5.
1996: Jean-Marc Sabatier; Kamel Mabrouk; Maxime Moulard; Hervé Rochat; Jurphaas van Rietschoten; Emmanuel Fenouillet
Anti-HIV activity of multibranched peptide constructs derived either from the cleavage sequence or from the transmembrane domain (gp41) of the human immunodeficiency virus type 1 envelope.
Virology 1996;223(2):406-8.
1996: Rym Barbouche; Naziha Marrakchi; Pascal Mansuelle; Mohamed Naceur Krifi; Emmanuel Fenouillet; Hervé Rochat; Mohamed El Ayeb
Novel anti-platelet aggregation polypeptides from Vipera lebetina venom: isolation and characterization.
FEBS letters 1996;392(1):6-10.
1996: Emmanuel Fenouillet; Raymond Miquelis; R Drillien
Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
Virology 1996;218(1):224-31.
1996: M J Papandreou; T Idziorek; Raymond Miquelis; Emmanuel Fenouillet
Glycosylation and stability of mature HIV envelope glycoprotein conformation under various conditions.
FEBS letters 1996;379(2):171-6.
1995: P Bastiani; M J Papandreou; O Blanck; Emmanuel Fenouillet; V Thibault; Raymond Miquelis
On the relationship between completion of N-acetyllactosamine oligosaccharide units and iodine content of thyroglobulin: a reinvestigation.
Endocrinology 1995;136(10):4204-9.
1995: Emmanuel Fenouillet; I M Jones
The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
The Journal of general virology 1995;76 ( Pt 6)():1509-14.
1995: Emmanuel Fenouillet; N Blanes; Abdelaziz Benjouad; Jean Claude Gluckman
Anti-V3 antibody reactivity correlates with clinical stage of HIV-1 infection and with serum neutralizing activity.
Clinical and experimental immunology 1995;99(3):419-24.
1995: Abdelaziz Benjouad; F Chapuis; Emmanuel Fenouillet; Jean Claude Gluckman
Multibranched peptide constructs derived from the V3 loop of envelope glycoprotein gp120 inhibit human immunodeficiency virus type 1 infection through interaction with CD4.
Virology 1995;206(1):457-64.
1994: Abdelaziz Benjouad; Kamel Mabrouk; Jean Claude Gluckman; Emmanuel Fenouillet
Effect of sialic acid removal on the antibody response to the third variable domain of human immunodeficiency virus type-1 envelope glycoprotein.
FEBS letters 1994;341(2-3):244-50.
1994: Emmanuel Fenouillet; Jean Claude Gluckman; I M Jones
Functions of HIV envelope glycans.
Trends in biochemical sciences 1994;19(2):65-70.
1993: Emmanuel Fenouillet; N Blanes; A Coutellier; Jean Claude Gluckman
Relationship between anti-p24 antibody levels and p24 antigenemia in HIV-infected patients.
AIDS research and human retroviruses 1993;9(12):1251-5.
1993: Emmanuel Fenouillet; N Blanes; A Coutellier; J Demarquest; W Rozenbaum; Jean Claude Gluckman
[Predictive value of the assay of serum anti-p25 antibodies in patients with human immunodeficiency virus (HIV-1) infection].
Annales de médecine interne 1993;144(5):329-34.
1993: Emmanuel Fenouillet; I Jones; B Powell; D Schmitt; M P Kieny; Jean Claude Gluckman
Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
Journal of virology 1993;67(1):150-60.
1992: Emmanuel Fenouillet; N Blanes; A Coutellier; J Demarquest; W Rozenbaum; Jean Claude Gluckman
Monitoring of antibodies against human immunodeficiency virus type 1 p25 core protein as prognostic marker.
The Journal of infectious diseases 1992;166(3):611-6.
1992: Y Morikawa; J P Moore; Emmanuel Fenouillet; I M Jones
Complementation of human immunodeficiency virus glycoprotein mutations in trans.
The Journal of general virology 1992;73 ( Pt 8)():1907-13.
1992: I M Jones; Y Morikawa; Emmanuel Fenouillet; J P Moore
Antigenicity of the HIV-2 V3 loop.
AIDS (London, England) 1992;6(8):888-9.
1992: Emmanuel Fenouillet; Jean Claude Gluckman
Immunological analysis of human immunodeficiency virus type 1 envelope glycoprotein proteolytic cleavage.
Virology 1992;187(2):825-8.
1991: Emmanuel Fenouillet; Jean Claude Gluckman
Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
The Journal of general virology 1991;72 ( Pt 8)():1919-26.
1991: Emmanuel Fenouillet; N Blanes; Jean Claude Gluckman
Gp160 of commercial HIV western blots is not gp160env. Should criteria for seropositivity be revised?
AIDS (London, England) 1991;5(6):770.
1990: Emmanuel Fenouillet; A M Sorensen; M Lacroix; A Coutellier; S Herson; C Fretz-Foucault; Jean Claude Gluckman
Early and specific diagnosis of seropositivity to HIVs by an enzyme-linked immunosorbent assay using env-derived synthetic peptides.
AIDS (London, England) 1990;4(11):1137-40.
1990: Emmanuel Fenouillet; Jean Claude Gluckman; Elmostafa Bahraoui
Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1.
Journal of virology 1990;64(6):2841-8.
1989: Jean-Marc Sabatier; B Clerget-Raslain; G Fontan; Emmanuel Fenouillet; Hervé Rochat; Claude Granier; Jean Claude Gluckman; Jurphaas van Rietschoten; Luc Montagnier; Elmostafa Bahraoui
Use of synthetic peptides for the detection of antibodies against the nef regulating protein in sera of HIV-infected patients.
AIDS (London, England) 1989;3(4):215-20.
1989: Emmanuel Fenouillet; B Clerget-Raslain; Jean Claude Gluckman; Denise Guétard; Luc Montagnier; Elmostafa Bahraoui
Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
The Journal of experimental medicine 1989;169(3):807-22.
1988: VIDA CHAMS; T Jouault; Emmanuel Fenouillet; Jean Claude Gluckman; David Klatzmann
Detection of anti-CD4 autoantibodies in the sera of HIV-infected patients using recombinant soluble CD4 molecules.
AIDS (London, England) 1988;2(5):353-61.